This technical datasheet details the optimal thermal preservation parameters, structural stability kinetics, and laboratory handling protocols for Long Arg3 Insulin-Like Growth Factor-1 (IGF-1 LR3). Designed for institutional researchers, this guide establishes baseline storage temperatures, reconstitution methodologies, and quality verification standards necessary to maintain biological activity in vitro.
This technical datasheet details the optimal thermal preservation parameters, structural stability kinetics, and laboratory handling protocols for Long Arg3 Insulin-Like Growth Factor-1 (IGF-1 LR3). Designed for institutional researchers, this guide establishes baseline storage temperatures, reconstitution methodologies, and quality verification standards necessary to maintain biological activity in vitro.
According to standard analytical specifications in this igf-1 lr3 lyophilized storage temperature datasheet, solid-state IGF-1 LR3 must be stored at -20°C for routine short-to-medium term storage (up to 24 months) or -80°C for ultra-long-term preservation exceeding two years. Desiccated lyophilized cakes remain stable at ambient temperatures (15°C to 25°C) for up to 30 days during transport, provided they are kept away from light and direct heat.
To ensure precise laboratory planning, researchers should consult the following baseline temperature control matrix prior to unsealing test vials:
• Extended Preservation (-80°C): Up to 36 months in desiccated, dark conditions without measurable loss of primary sequence integrity.
• Standard Storage (-20°C): 12 to 24 months stability; recommended baseline for active experimental inventories.
• Refrigerated Storage (2°C to 8°C): Stable for up to 90 days in lyophilized state; recommended prior to immediate reconstitution.
• Ambient Transit (15°C to 25°C): Stable up to 30 days; minimal risk of primary structure oxidation or cleavage during short-term courier transit.
Long Arg3 Insulin-Like Growth Factor-1 is an 83-amino-acid analog of human IGF-1, engineered with an arginine substitution for glutamic acid at position 3, alongside a 13-amino-acid N-terminal extension peptide. In cell culture models, these modifications significantly decrease binding affinity to endogenous insulin-like growth factor binding proteins (IGFBPs). As a result, IGF-1 LR3 exhibits a higher proportion of free, biologically active ligand capable of binding the type 1 IGF receptor (IGF-1R).
Because of this modified molecular structure, maintaining tertiary conformational stability is critical. Environmental stressors—such as temperature spikes, pH shifts, or shear forces—can induce partial unfolding or irreversible aggregation. When evaluating active ligands within our research library, investigators must adhere strictly to environmental temperature limits to preserve the peptide's receptor-binding kinetics.
Maintaining rigorous quality control standards is essential when sourcing research compounds for quantitative in vitro assays. PX1 Research enforces strict manufacturing and analytical criteria for every lot of synthesized peptides. Researchers requiring high-purity materials can review our complete catalog of all peptides to compare structural profiles and verification data.
Every batch of lyophilized peptide undergoes comprehensive analytical testing before distribution to research facilities:
• High-Performance Liquid Chromatography (RP-HPLC): Confirms physical purity exceeding 98.0%, verifying the absence of truncated synthesis fragments or oxidized side-products.
• Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular mass (9,111.6 Da expected theoretical mass) against reference standards.
• Bacterial Endotoxin Assay (LAL Test): Ensures endotoxin levels remain below 0.01 EU/μg, preventing non-specific inflammatory signaling in cell culture models.
• ISO 17025 Accredited Laboratory Verification: Third-party Certificates of Analysis (COAs) are generated for every individual lot to guarantee complete analytical transparency.
• US Manufacturing Compliance: Produced in state-of-the-art, GMP-compliant facilities located in the USA, supported by secure cold-chain fulfillment out of California and Arizona.
Once reconstituted into aqueous solution, the thermal stability of IGF-1 LR3 drops significantly compared to its solid lyophilized form. To maximize working solution shelf life, researchers should follow a standardized laboratory protocol. First, allow the lyophilized vial to equilibrate to room temperature (20°C to 25°C) for 20 minutes before reconstitution to minimize condensation inside the vial.
Reconstitute the cake using sterile 0.1M acetic acid or 10mM hydrochloric acid (pH 2.0–3.0) to yield a stock solution concentration between 0.1 mg/mL and 1.0 mg/mL. Acidified solutions prevent rapid peptide aggregation and surface adsorption to glass or plastic container walls. For extended liquid stability, dilute further with phosphate-buffered saline (PBS) containing 0.1% Bovine Serum Albumin (BSA) immediately prior to performing assays. Detailed methodologies are outlined in our dedicated peptide storage and reconstitution guide.
The liquid-phase shelf life of reconstituted IGF-1 LR3 depends heavily on holding temperature and solution pH:
• Frozen Solution (-20°C to -80°C): Acidified stock solutions remain stable for up to 3 to 6 months. Repeated freeze-thaw cycles must be avoided by creating single-use aliquots.
• Refrigerated Solution (2°C to 8°C): Acidified stock solutions remain stable for 14 to 21 days. Non-acidified neutral solutions (e.g., in plain saline) degrade rapidly within 24–48 hours.
• Ambient Liquid (20°C to 25°C): Reconstituted solutions experience measurable peptide degradation within 4 to 8 hours due to deamidation and oxidation.
To prevent loss of experimental active concentration, liquid aliquots should be prepared using low-protein-binding polypropylene microcentrifuge tubes and stored immediately at target temperatures.
Understanding the primary degradation pathways of Long Arg3 IGF-1 helps researchers prevent loss of activity during long-term experimental protocols. When exposed to elevated temperatures (>37°C) or basic pH environments, the peptide primary structure undergoes specific chemical transformations.
The primary degradative routes include methionine oxidation (specifically at position 26), glutamine/asparagine deamidation, and disulfide bond scrambling. In vitro assays demonstrate that oxidized IGF-1 LR3 exhibits significantly reduced affinity for IGF-1R, leading to inconsistent cell proliferation rates. Furthermore, mechanical agitation of warm solutions promotes hydrophobic aggregation, producing visible micro-precipitates that render the material unsuitable for quantitative assay protocols.
When designing in vitro tissue signaling models, investigators often compare IGF-1 LR3 to related analogs and upstream growth hormone secretagogues. Each compound possesses unique tertiary stability profiles, half-lives, and receptor-binding dynamics.
For instance, IGF-1 DES lacks the N-terminal tripeptide (Gly-Pro-Glu), making it hyper-potent in localized, low-pH cellular microenvironments, though it exhibits a considerably shorter liquid half-life than IGF-1 LR3. Researchers interested in broader receptor systems can review our IGF-1 DES research guide for specific comparative parameters. Conversely, growth hormone secretagogues such as CJC-1295 No DAC act via g-protein coupled receptors (GHSR-1a) to induce endogenous GH production rather than signaling directly through IGF-1R. An overview of these mechanisms is available in our growth hormone secretagogues overview. Institutional purchasing departments seeking bulk volumes for comparative study series can establish account frameworks via our wholesale portal.
To guarantee that research-grade peptides maintain their specified structural parameters upon arrival, PX1 Research utilizes optimized cold-chain packaging and fulfillment protocols. All orders placed Monday through Friday ship same-day from distribution centers located in California and Arizona.
Lyophilized vials are packed in insulated containers with temperature-stabilized ice packs to mitigate thermal stress during transit. Upon receipt of shipment, laboratory personnel should immediately inspect the integrity of the vial seal, confirm the presence of a dry, intact lyophilized cake, and transfer the material directly to -20°C or -80°C storage facilities. Prolonged exposure of unboxing items to ambient room temperatures should be avoided.
What is the primary target temperature in the igf-1 lr3 lyophilized storage temperature datasheet?
According to the igf-1 lr3 lyophilized storage temperature datasheet, the optimal long-term storage temperature for dry lyophilized powder is -20°C for up to 24 months, or -80°C for extended stability reaching 36 months.
How long is lyophilized IGF-1 LR3 stable at room temperature during shipping?
Lyophilized IGF-1 LR3 is stable at ambient temperatures (15°C to 25°C) for up to 30 days without significant structural degradation, provided it is kept desiccated and protected from light.
What is the recommended storage temperature for reconstituted IGF-1 LR3 liquid?
Reconstituted IGF-1 LR3 in an acidified stock solution should be stored at 2°C to 8°C for short-term use (up to 21 days) or single-use aliquoted and frozen at -20°C to -80°C for up to 6 months.
Why must IGF-1 LR3 be reconstituted in an acidic solution?
Acidic solutions (0.1M acetic acid or 10mM HCl, pH 2.0–3.0) prevent hydrophobic aggregation and surface adsorption to storage container walls, maintaining peptide solubility and bioactivity.
Can reconstituted IGF-1 LR3 undergo multiple freeze-thaw cycles?
No. Freeze-thaw cycles induce mechanical stress and thermal fluctuations that denature the peptide structure and cause aggregation. Reconstituted stock should be aliquoted into single-use microcentrifuge tubes prior to freezing.
What endotoxin limit is acceptable for IGF-1 LR3 in laboratory cell culture?
PX1 Research guarantees endotoxin levels below 0.01 EU/μg via chromogenic LAL testing, preventing non-specific inflammatory reactions in sensitive cell culture protocols.
How do I verify the purity and molecular weight of my IGF-1 LR3 lot?
Every lot supplied by PX1 Research includes a lot-specific Certificate of Analysis (COA) containing RP-HPLC traces demonstrating ≥98% purity and ESI-MS spectrum confirming the 9,111.6 Da molecular weight.
What is the difference in stability between IGF-1 LR3 and native IGF-1?
IGF-1 LR3 contains an amino acid substitution and an N-terminal extension that drastically reduce binding to IGFBPs, giving it increased biological availability in vitro, though its liquid handling protocols mirror those of native IGF-1.
How should laboratory personnel unpack and store incoming IGF-1 LR3 shipments?
Upon receiving, inspect the package integrity, verify the lyophilized cake is intact, and immediately transfer the vials to a -20°C or -80°C freezer, minimizing exposure to ambient temperatures.
Where are PX1 Research peptides synthesized and dispatched from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities and dispatched same-day (M–F) from distribution hubs in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.